Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Clinical Diagnosis Track

Bone Marrow infiltration in Pre-therapy assessment of pediatric lymphoma patients; FDG PET/CT versus BMB.

Salma Badr, Magdy Kotb, Mai Abdelwahab and Hosna Moustafa
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 643;
Salma Badr
2National Cancer Institute Egypt Cairo Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Magdy Kotb
2National Cancer Institute Egypt Cairo Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mai Abdelwahab
2National Cancer Institute Egypt Cairo Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hosna Moustafa
1Kasr al Ainy Cairo Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

643

Objectives: To compare between FDG PET/CT and routine iliac BMB in initial assessment of bone marrow infiltration in pediatric lymphoma patients.

Methods: 140 pediatric patients with pathologically proven lymphoma [113 Hodgkin’s disease (HD), 27 non- Hodgkin’s lymphoma (NHL)] were enrolled in this study. All patients had pre therapy FDG PET/CT and BMB within a period not exceeding two weeks apart. Clinico-pathological and other radiological data were extracted from registration file.

Results: Among the 113 HD patients FDG PET/CT revealed positive BM involvement in 27 patients, 2 of which proved to be falsely positive with negative BMB & regional MRI results. On the other hand BMB was positive for BM infiltration in 8 patients all of which were also positive in PET/CT. In NHL group FDG PET/CT revealed positive BM involvement in 14 patients, only 6 of them have positive BMB. None of patient has positive BMI by BMB & negative FDG PET/CT for BM infiltration in both groups. The overall results revealed significant higher sensitivity for FDG PET/CT (100%) compared to BMB (35.9%) (P<0.05). FDG PET-CT provides upstaging in 17.9 % of the enclosed patients.

Conclusion: FDG PET/CT seemed to be a promising alternative tool to BMB in assessment of BMI at initial assessment of HD & NHL pediatric lymphoma. Its high sensitivity & upstaging impact stand behind. Research Support: No support

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Bone Marrow infiltration in Pre-therapy assessment of pediatric lymphoma patients; FDG PET/CT versus BMB.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Bone Marrow infiltration in Pre-therapy assessment of pediatric lymphoma patients; FDG PET/CT versus BMB.
Salma Badr, Magdy Kotb, Mai Abdelwahab, Hosna Moustafa
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 643;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Bone Marrow infiltration in Pre-therapy assessment of pediatric lymphoma patients; FDG PET/CT versus BMB.
Salma Badr, Magdy Kotb, Mai Abdelwahab, Hosna Moustafa
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 643;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Clinical Diagnosis Track

  • Immunohistochemical analysis of Gastrin-Releasing-Peptide receptor (GRPr) and Prostate-Specific- Membrane Antigen (PSMA) in primary prostate cancer: comparison with radiolabeled GRPr antagonist (68Ga-RM2) PET/CT
  • Relationship between FDG PETCT imaging and CA 125 levels in treated patients with Ovarian cancers - Can FDG PETCT define and predict the disease burden in clinically suspected recurrence ?
  • Clinical Experience with 18F-fluciclovine (Axumin) in Prostate Cancer Patients with a Rising PSA After Primary Treatment
Show more Oncology, Clinical Diagnosis Track

Lymphoma - Paediatrics and MRI

  • Evaluation of inter-observer reliability and assessment of PET SUV-based quantification of 5-point Deauville score in FDG PET/CT in a COG pediatric high risk Hodgkin lymphoma trial (AHOD0831)
  • 18F-FDG PET/CT for Detection of Bone Marrow Involvement in Children and Adolescents with Non-Hodgkin Lymphoma.
  • Prognostic impact of positive versus negative FDG PET/CT for bone marrow infiltration in initially evaluated pediatric lymphoma patients.
Show more Lymphoma - Paediatrics and MRI

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire